The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AZD; Clovis Oncology; Ellipses Pharma; GlaxoSmithKline; Merck; Shigoni
Speakers' Bureau - AZD; Clovis Oncology; GlaxoSmithKline; Roche
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AZD; GlaxoSmithKline
Efficacy and safety of dostarlimab in patients (pts) with mismatch repair deficient (dMMR) solid tumors: Analysis of 2 cohorts in the GARNET study.
 
Thierry Andre
Honoraria - AMGEN; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Pierre Fabre; Roche/Genentech; SERVIER; Ventana Medical Systems
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; GamaMabs Pharma; GlaxoSmithKline; Gritstone Bio; Kaleido Biosciences; MSD Oncology; Pierre Fabre; Seagen; Servier; SERVIER; Tesaro; Transgene
Travel, Accommodations, Expenses - MSD Oncology
(OPTIONAL) Uncompensated Relationships - Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group; ARCAD Foundation; Gercor
 
Dominique Berton
No Relationships to Disclose
 
Giuseppe Curigliano
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daichi-Sankyo; Foundation Medicine; GlaxoSmithKline; Guardant Health; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Speakers' Bureau - Daiichi Sankyo; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Begona Jimenez-Rodriguez
Speakers' Bureau - Lilly; Roche
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche
 
Susan Ellard
Stock and Other Ownership Interests - GlaxoSmithKline
 
Adriano Gravina
Travel, Accommodations, Expenses - Pfizer
 
Rowan Miller
No Relationships to Disclose
 
Anna Tinker
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca/MedImmune (Inst)
Other Relationship - AstraZeneca
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline
 
Andrea Jewell
No Relationships to Disclose
 
Joanna Pikiel
Honoraria - Amgen; Clovis Oncology; GlaxoSmithKline; Incyte; Novartis; Odonate Therapeutics; Pfizer; Regeneron; Roche
Travel, Accommodations, Expenses - Roche
 
Ana Oaknin
Consulting or Advisory Role - AGENUS; Amgen; AstraZeneca; Clovis Oncology; Corcept Therapeutics; Deciphera; Eisai; EMD Serono; Genmab; GlaxoSmithKline; Immunogen; ITeos Therapeutics; Medison; Merck Sharp & Dohme; Mersana; Novocure; PharmaMar; prIME Oncology; Roche; Roche; Shattuck Labs; Sutro Biopharma; Tesaro
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Agenus (Inst); Aprea Therapeutics (Inst); AstraZeneca (Inst); BeiGene (Inst); Belgian Gynaecological Oncology Group (Inst); Bristol-Myers Squibb International Corporation (BMS) (Inst); Clovis Oncology (Inst); Corcept Therapeutics (Inst); Eisai (Inst); Immunogen (Inst); Iovance Biotherapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Medimmune (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Mundipharma Research (Inst); Novartis Farmacéutica (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst); Seagen (Inst); Sutro Biopharma (Inst); Tesaro (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Tao Duan
Employment - GlaxoSmithKline
 
Sybil Zildjian
Employment - GlaxoSmithKline
 
Eleftherios Zografos
Employment - GlaxoSmithKline
 
Jennifer Taylor Veneris
Employment - GlaxoSmithKline
 
Susana N. Banerjee
Honoraria - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Mersana; MSD Oncology; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; GenMab; GlaxoSmithKline; Immunogen; Merck Serono; Mersana; MSD Oncology; OncXerna Therapeutics; Seagen; Shattuck Labs
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst)